Latest

Trackers› Clinical trials› Zhengzhou

Clinical trial register · China

Clinical Trials in Zhengzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC

19052

Studies in scope

all four open statuses

11786

Recruiting now

open to new participants

2009

Lead sponsors

across recruiting studies

Top sites

Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343

Trials with a site in Zhengzhou

Status

Study

Lead sponsor

Phase

Enrol

Chinese sites

Start

Active, closed

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

NCT03755791Hepatocellular Carcinoma

Exelixis

Phase 3

837

Hefei, Fuzhou, Xiamen, Guangzhou, Harbin, Zhengzhou, Changsha, Nanjing

2018-06-10

Active, closed

Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer

NCT03519230Ovarian Cancer

BeiGene

Phase 3

224

Hefei, Beijing, Chongqing, Guangzhou, Shantou, Nanning, Harbin, Zhengzhou

2018-05-14

Active, closed

Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

NCT03315364Recurrent or Metastatic Breast Cancer

Daehwa Pharmaceutical Co., Ltd.

Phase 2/3

549

Hefei, Beijing, Guangzhou, Haikou, Harbin, Zhengzhou, Nanjing, Changchun

2017-12-18

Recruiting

China Health Big Data

NCT03699228Osteoporosis, Obesity, Liver Steatoses

Beijing Jishuitan Hospital

Observational

30,000

Wuhu, Beijing, Guiyang, Zhengzhou, Shanghai

2017-12-01

Active, closed

BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients

NCT03369977Type A Aortic Dissection

CryoLife, Inc.

Not applicable

202

Beijing, Nanjing, Shanghai, Wuhan, Zhengzhou

2017-11-01

Active, closed

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

NCT03336333Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

BeiGene

Phase 3

590

Hefei, Beijing, Chongqing, Fuzhou, Quanzhou, Guangzhou, Zhengzhou, Wuhan

2017-10-31

Active, closed

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02966756Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)

AbbVie

Phase 2

66

Hefei, Beijing, Fuzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha

2017-10-12

Active, closed

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer

NCT03155997Breast Cancer

Eli Lilly and Company

Phase 3

5,637

Beijing, Fuzhou, Guangzhou, Harbin, Zhengzhou, Changsha, Nanjing, Jinan

2017-07-12

Active, closed

Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation

NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute

Institut de Recherches Internationales Servier

Phase 3

146

Zhengzhou, Chengdu, Beijing, Guangzhou, Hangzhou, Tianjin

2017-06-26

Active, closed

A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

NCT02993523Acute Myeloid Leukemia (AML)

AbbVie

Phase 3

443

Fuzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Changchun, Shanghai

2017-02-02

Recruiting

MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence

NCT04215211Glioma

The First Affiliated Hospital of Zhengzhou University

Observational

2,500

Zhengzhou

2017-01-01

Recruiting

Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence

NCT04217044Glioma

The First Affiliated Hospital of Zhengzhou University

Observational

3,000

Zhengzhou

2017-01-01

Recruiting

Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence

NCT04215224Glioma

The First Affiliated Hospital of Zhengzhou University

Observational

3,500

Zhengzhou

2017-01-01

Recruiting

MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence

NCT04217018Glioma

The First Affiliated Hospital of Zhengzhou University

Observational

3,000

Zhengzhou

2017-01-01

Active, closed

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer

NCT02763566Breast Cancer

Eli Lilly and Company

Phase 3

463

Bengbu, Beijing, Fuzhou, Guangzhou, Nanning, Shijiazhuang, Harbin, Zhengzhou

2016-12-05

Recruiting

China Registry for Genetic / Metabolic Liver Diseases

NCT03131427Genetic/Metabolic Liver Diseases

Beijing Friendship Hospital

Observational

20,000

Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Shanghai, Chengdu, Tianjin, Ürümqi

2015-06-13

Recruiting

Registry of Multicenter Brain-Heart Comorbidity in China

NCT05961748Ischemic Heart Disease, Cardiac Arrest, Atrial Fibrillation, Heart Failure

Beijing Tiantan Hospital

Observational

100,000

Beijing, Fuzhou, Xiamen, Shenzhen, Harbin, Zhengzhou, Shanghai, Shanxi

2012-01-01

Recruiting

Azoospermia Patients

NCT03991663Healthy Related

The First Affiliated Hospital of Zhengzhou University

Observational

10,000

Zhengzhou

2010-01-01

Recruiting

Primary Ovarian Insufficient Patients

NCT03989154Healthy Related

The First Affiliated Hospital of Zhengzhou University

Observational

10,000

Zhengzhou

2010-01-01

Recruiting

Newborns From Patients Treated With ART (Assisted Reproductive Technology)

NCT03993158Health Related

The First Affiliated Hospital of Zhengzhou University

Observational

10,000

Zhengzhou

2010-01-01

Recruiting

PCOS (Polycystic Ovarian Syndrome) Patients

NCT03991507Health Related

The First Affiliated Hospital of Zhengzhou University

Observational

10,000

Zhengzhou

2010-01-01

Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/zhengzhou?page=10

Query this register directly

GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 921 of those studies with a site in Zhengzhou.

How many clinical trials are recruiting in Zhengzhou?

553 of the 921 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 163 have not yet opened recruitment, 191 are active but closed to new participants, and 14 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.